UNSPSC 51432800: Antihypertensive oligopeptides

Antihypertensive drugs made from 2-12 amino acids, or includes dipeptides, tripeptides, tetrapeptides, and pentapeptides.

UNSPSC 51432800 Antihypertensive oligopeptides is a Class code under which state and local governments procure pharmaceutical products, primarily emergency medications and generic multi-source drugs for distribution through government health systems, fire rescue services, and pharmacy benefit programs. Recent solicitations show that state and local buyers under this code are purchasing specific branded medications (labetalol, epinephrine, adenosine, diltiazem) for emergency medical use, as well as establishing framework agreements with manufacturers for generic pharmaceuticals distributed through authorized wholesalers to multiple state and local agencies. Issuing bodies include municipal procurement offices (such as the City of Tampa), state health and human services agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). These buyers range from single-jurisdiction fire rescue services to multi-state consortia coordinating purchases across government facilities.

Activity spans Florida, Texas, and Minnesota through recent solicitations posted between January and April 2026. The City of Tampa's Purchasing Department issued an Invitation for Bid (26P00188) for Advanced Life Support Medications on April 24, 2026, requiring sealed bids for 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with a bid due date of April 8, 2026 and an estimated contract value of $40,000. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) on April 3, 2026 to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP (S1070000015802) due March 26, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products for distribution across participating state and local government facilities including Oregon, with products to become available by May 15, 2026 and resulting agreements effective July 1, 2026.